Product Information

TOVET EMOLLIENT 0.05% FOAM is a generic product labeled by Medimetriks Pharmaceuticals Inc., priced at $1.8556 per GM under NDC 43538095210. Its NADAC has been published 279 times since May 20, 2020.

FDA first approved this application on Aug 14, 2012. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the CLOBETASOL PROPIONATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TOVET EMOLLIENT 0.05% FOAM

CLOBETASOL PROPIONATE
$1.8556per GM
High Outlier

Strength

.5 mg/g

NDC

43538095210

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

CLOBETASOL PROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201402

FDA Approved

8/14/2012

TE Code

AB2

On Market Since

2/1/2013

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for TOVET EMOLLIENT 0.05% FOAM has been published 279 times since May 20, 2020, and over the history we have for it it has declined 43.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8556 per GM
All-time high$3.2827 (May 12, 2021)
All-time low$0.8672 (Aug 21, 2024)
52-week high$2.5158
52-week low$1.8556
Median price$2.3884
Average price$2.3473
Largest weekly change+35.3% (Feb 18, 2026)
Weeks tracked279
Tracking sinceMay 20, 2020

Price History

1W

-6.3%

1M

-6.3%

3M

-16.4%

6M

-26.2%

1Y

-0.2%

3Y

-22.3%

5Y

-43.5%

All

-43.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLOBETASOL PROPIONATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of TOVET EMOLLIENT 0.05% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for TOVET EMOLLIENT 0.05% FOAM, manufactured by Medimetriks Pharmaceuticals Inc., is $1.8556 per GM (NDC 43538095210), effective Aug 19, 2026.

How has the price of TOVET EMOLLIENT 0.05% FOAM changed over time?

Over the history we have for it, the NADAC for TOVET EMOLLIENT 0.05% FOAM has declined 43.5%. It has been tracked across 279 weekly CMS publications since May 20, 2020.

What are the highest and lowest recorded NADAC prices for TOVET EMOLLIENT 0.05% FOAM?

Since May 20, 2020, the NADAC for TOVET EMOLLIENT 0.05% FOAM has ranged from a low of $0.8672 (Aug 21, 2024) to a high of $3.2827 (May 12, 2021), with a median of $2.3884 per GM.

Are there cheaper alternatives to TOVET EMOLLIENT 0.05% FOAM?

No other NADAC-published product currently shares the active ingredient and strength of TOVET EMOLLIENT 0.05% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TOVET EMOLLIENT 0.05% FOAM?

TOVET EMOLLIENT 0.05% FOAM (NDC 43538095210) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a generic product.